- Category
- Medium (2024-25)
- Udyam number
- UDYAM-TN-02-0061034

About Hfa Formulations Private Limited
Data last updated:
Hfa Formulations Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 February 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U33110TN2015PTC099069. Its GSTIN is 05AAECH0740B1ZC (Uttarakhand). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Ramkumar Srinivasan and Muthukaruppan Srinivasan.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 76 Ae Block Iiird Street Anna Nagar, Chennai, Tamil Nadu, India – 600040.
As per the financials filed for FY 2024, the company reported a revenue of ₹15.65 Cr, a growth of 42% compared to the previous year. For the same year it recorded a net loss of ₹6.71 Cr (net margin -42.9%) and EBITDA of -₹92.46 Lakh (EBITDA margin -5.9%). Revenue has grown at a compounded annual rate (CAGR) of 485% over three years.
The company has about 22 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹4.18 Cr on record.
Hfa Formulations Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0061034). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website taxmarket.in.
Company details
Recognitions & Rankings of Hfa Formulations
Contact details
Hfa Formulations Private Limited's registered office is in Chennai, Tamil Nadu. Its website is taxmarket.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address76 Ae Block Iiird Street Anna Nagar, Chennai, Tamil Nadu, India – 600040
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Hfa Formulations Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Hfa Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Hfa Formulations Private Limited, buy the company report.
Financials of Hfa Formulations Private Limited
FY 2024 filings availableHfa Formulations Private Limited reported revenue of ₹15.65 Cr (up 42% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 485% over three years, including 42% growth in the latest year. EBITDA rose 48% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹92.46 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹6.71 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -5.9% | ||||
| Net Profit Margin | -42.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hfa Formulations Private Limited, buy the company report.
Board of directors of Hfa Formulations Private Limited
Hfa Formulations has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramkumar Srinivasan Also directs: Cu-V-Kar Genetic Medicine Private Limited, Cu-V-Kar Pharmacuticals Private Limited, MM Pharma Medicines Private Limited and 1 more | Director | 29 Apr 2021 | 5 Years 6 Months | Current |
| Muthukaruppan Srinivasan Also directs: Cu-V-Kar Genetic Medicine Private Limited, Cu-V-Kar Pharmacuticals Private Limited, MM Pharma Medicines Private Limited and 1 more | Director | 14 Jun 2019 | 7 Years 5 Months | Current |
Peer comparison
Hfa Formulations Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Oshino Drugs Private Limited | ₹15.75 Cr (FY 2025) | -15.0% | New Delhi, Delhi, India | |||
| Suma Pharmaceuticals Private Limited | ₹15.75 Cr (FY 2024) | 9.0% | Ambernath, Maharashtra, India | |||
| Syntho Pharmaceuticals Private Limited | ₹15.7 Cr (FY 2025) | -3.0% | Uttar Pradesh, India | |||
| Hfa Formulations Private Limitedthis company | ₹15.65 Cr (FY 2024) | -₹6.71 Cr | -42.9% | 42.0% | 22 | Chennai, Tamil Nadu, India |
| Eamon Drugs Private Limited | ₹15.64 Cr (FY 2025) | 24.0% | Indore, Madhya Pradesh, India | |||
| Zuche Pharmaceuticals Private Limited | ₹15.59 Cr (FY 2025) | -14.0% | Delhi, India | |||
| Jagannath Chemical and Pharmaceutical Works Pvt Ltd | ₹15.58 Cr (FY 2024) | 25.0% | Cuttack, Odisha, India | |||
| Bhanu Healthcare Private Limited | ₹15.58 Cr (FY 2022) | 18.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Hfa Formulations Private Limited, buy the company report.
Auditor
Hfa Formulations Private Limited is audited by YASHWANTH PESALA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| YASHWANTH PESALA & ASSOCIATES | FY 2023 | 018009S |
Shareholding
The shareholding of Hfa Formulations Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Hfa Formulations Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Nov 2022 | 100647203 | Others | ₹98 Lakh | Open | |
| 20 Oct 2022 | 100619382 | Others | ₹2 Cr | Open | |
| 07 Sep 2021 | 100497186 | Indian Overseas Bank | ₹1.2 Cr | Open |
To see the full charge records of Hfa Formulations Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Hfa Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hfa Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Hfa Formulations Private Limited has a workforce of 22 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 22 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 |
To see the full employee and EPFO history of Hfa Formulations Private Limited, buy the company report.
GST
Hfa Formulations has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAECH0740B1ZC | Uttarakhand | Active | 29 Mar 2019 |
To see the full GST registrations and return filing status of Hfa Formulations Private Limited, buy the company report.
Recent activity
Hfa Formulations Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Ramkumar Kanmanipriya ceased to be Director on 29 Apr 2021.
Frequently asked questions
Hfa Formulations is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 February 2015 (11+ years old) and is registered under CIN U33110TN2015PTC099069.
Hfa Formulations has 2 current directors:
- Ramkumar Srinivasan - Director
- Muthukaruppan Srinivasan - Director
The latest financial statements of Hfa Formulations on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Hfa Formulations is 05AAECH0740B1ZC, registered in Uttarakhand. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Hfa Formulations is U33110TN2015PTC099069. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hfa Formulations was incorporated on 03 February 2015, making it 11+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Hfa Formulations by revenue are Oshino Drugs Private Limited, Suma Pharmaceuticals Private Limited, Syntho Pharmaceuticals Private Limited, Eamon Drugs Private Limited, Zuche Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ramkumar Kanmanipriya ceased to be Director on 29 Apr 2021. Ramkumar Srinivasan was appointed as Director on 29 Apr 2021. Muthukaruppan Srinivasan was appointed as Director on 14 Jun 2019. Hfa Formulations has 4 board changes on record in total.
Yes, Hfa Formulations is registered as a medium enterprise under Udyam registration (number: UDYAM-TN-02-0061034).
Hfa Formulations can be reached through the website taxmarket.in. Its registered office is in Chennai, Tamil Nadu, India.
The registered office of Hfa Formulations is at 76 Ae Block Iiird Street Anna Nagar, Chennai, Tamil Nadu, India – 600040.

